Recent bladder cancer studies have shown that genetic mutations in bladder epithelial cells frequently occur in FGFR3, PIK3CA, and RAS (all associated with RAS signaling networks) (Bockorny et al., 2018; Tsujino et al., 2019). This evidence concerns the gene PIK3CA and urinary bladder cancer.